Discontinuing Prophylactic Transfusions Used to Prevent Stroke in Sickle Cell Disease
The Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators
- 29 Dec, 2005
This
PowerPoint Slide Set is a value
added service that requires an individual subscription.
Already a print subscriber? Activate your online access
Not a Subscriber?
Get full access to NEJM Online now with a FREE TRIAL!
Or, purchase full access to this
PowerPoint Slide Set for $10
